Navigation Links
Leading Cardiologist Joins Ontario Research Firm to Conduct New Clinical Trial on the Effect of Pantethine on Cholesterol Levels
Date:9/25/2008

Dr. John A. Rumberger and KGK Synergize Will Study Ingredient's

Impact on North Americans

NEW YORK, Sept. 25 /PRNewswire/ -- Daiichi Fine Chemical Co., Ltd. of Japan today announced that it has selected world-renowned Cardiologist Dr. John A. Rumberger and the Contract Research Division of KGK Synergize Inc. to launch a new clinical trial to investigate the effect of Pantethine as a dietary supplement for lipid management and the reduction of cardiovascular risk factors in the North American population.

The randomized, double-blind placebo controlled study will be conducted in two North American locations by Ontario-based KGK under the direction of Dr. Dale Wilson, KGK medical director and principal investigator for the study.

An internationally recognized specialist in preventive cardiology, Rumberger currently is director of cardiac imaging at the Princeton (N.J.) Longevity Center, clinical professor of medicine at Ohio State University and former professor of medicine at the Mayo Clinic. He also is author of 'The Way Diet' which provides information about optimal diet, supplementation, exercise and stress management in preventing heart disease. He will offer consultation on protocol design and comment on the findings of the clinical trial.

The study design process started last month, study subjects at low to moderate risk levels of cardiovascular disease will be treated over a 16-week period, and results are expected by the third quarter of 2009.

Daiichi Fine Chemical, sponsor of the study, is the world's leading supplier of pantothenic acid (vitamin B5) and its derivatives, including pantethine, marketed under the brand name Pantesin(R). Sold in Japan for more than 35 years, Pantesin has been available as a dietary supplement in the United States since 1992. Although Pantesin's effectiveness in safely lowering cholesterol levels has been documented in more than 30 clinical studies, the new study will be the most expansive ever conducted using North American subjects.

"Maintaining an optimal balance among LDL, HDL, and triglycerides is more important than simply lowering cholesterol and key to cardiovascular health," Rumberger said. "A low-fat and modified carbohydrate diet, exercise and regular consumption of dietary supplements formulated with scientifically proven, high quality ingredients can help individuals achieve a healthy blood lipid profile.

"A large body of research points to Pantethine's effectiveness in Asian and Western European populations, where oral administration of Pantethine has consistently shown an ability to favorably impact a variety of risk factors in people with hypercholesterolemia, arteriosclerosis and diabetes. The aim of the current trial is to confirm these results in a clinical setting in North America where cardiovascular disease is the leading cause of death."

Founded in 1997 by three scientists associated with the Centre for Human Nutrition at The University of Western Ontario, KGK maintains a global reputation for uncompromising science focused on nutraceutical, biotechnology and pharmaceutical product research.

"Our team of research experts is devoted to discovering the unique properties inherent in natural products that enhance and promote a healthy lifestyle," said KGK President and Chief Executive Officer Najla Guthrie. "Our in-house lab and clinic along with our location at a leading

scientific and medical research center ensure timely and conclusive research results overseen by leading physicians in the area of study."

Daiichi Fine Chemical is a global leader in researching the use of pantethine. By commissioning this new clinical trial, Daiichi signals its continued support of research that takes into account lifestyle changes and breakthrough discoveries that may impact the role Pantethine can play in enhancing cardiovascular health.

About Daiichi Fine Chemical

Daiichi Fine Chemical Co. Ltd., is the world's largest supplier of the cholesterol-management agent pantethine, a derivative of vitamin B5, which it markets under the brand name Pantesin(R). Daiichi Fine Chemical has a reputation of strict pharmaceutical GMP standards at the firm's vertically integrated operation in Japan which are applied to Pantesin(R). Kyowa Hakko Kogyo Co., Ltd., Japan acquired all shares of Daiichi Fine Chemical from Daiichi-Sankyo Co., Ltd. in 2007. As a wholly owned subsidiary in Kyowa's bio-chemical business, Daiichi Fine Chemical continues to supply vitamin B5 of highest quality standards. For more information visit http://www.daiichi-fcj.co.jp

About KGK Synergize, Inc.

Created in 1997 by three experienced nutritional scientists from University of Western Ontario to facilitate commercialization of research and development findings, KGK Synergize, Inc. provides contract research services to health nutrition, biotechnology and pharmaceutical industries. In addition to providing contract research services, KGK's Product Development Division brings new and innovative natural health products to the point where they are ready to be manufactured and marketed. For more information visit http://www.kgksynergize.com


'/>"/>
SOURCE Daiichi Fine Chemical Co., Ltd. of Japan
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Leading Healthcare System Decreases MRSA Infection Rate by 53 Percent - Offers Protocol & Educational Materials Free of Charge to Other Organizations
2. Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First Real World, All Comers Clinical Study
3. FDA Lifts Clinical Hold on Gentas Tesetaxel, a Leading Oral Taxane
4. Leading Academic Institutions Collaborate on 800-Patient Study of Effectiveness of Cryoablation for Men With Recurrent Prostate Cancer
5. Leading Immunologists Convene in Boston
6. XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
7. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
8. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist
9. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
10. Leading AIDS Groups Turn Up The Heat on 08 Presidential Candidates
11. Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... , ... PawPaws brand pet supplements owned by Whole Health Supply ... health of felines. The formula is all-natural and is made from Chinese herbs that ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
Breaking Medicine News(10 mins):